AndersonGM, LombrosoPJ: Genetics of childhood disorders: XLV. Autism, part 4: Serotonin in autism. J Am Acad Child Adolesc Psychiatry, 41:1513–1516, 2002.
2.
CaponeGT, GoyalP, GradosM, SmithB, KammannH: Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study. J Dev Behav Pediatr, 29:106–116, 2008.
3.
CorrellCU, ManuP, OlshanskiyV, NapolitanoB, KaneJM, MalhotraAK: Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA, 302:1765–1773, 2009.
4.
DaviesMA, ShefflerDJ, RothBL: Aripiprazole: A novel atypical antipsychotic drug with a uniquely robust pharmacology. CNS Drug Rev, 10:317–336, 2004.
5.
DeLeonA, PatelN, CrimsonM: Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clin Ther, 26:649–666, 2004.
6.
DresslerA, PerelliV, BozzaM, BargagnaS: The autistic phenotype in Down syndrome: Differences in adaptive behaviour versus Down syndrome alone and autistic disorder alone. Funct Neurol, 26:151, 2011.
7.
GibbsMV, ThorpeJG: Personality stereotype of noninstitutionalised Down syndrome children. Am J Ment Defic, 87:601–605, 1983.
8.
HowlinP, WingL, GouldJ: The recognition of autism in children with Down syndrome‐implications for intervention and some speculations about pathology. Dev Med Child Neurol, 37:406–414, 1995.
MarcusRN, OwenR, KamenL, ManosG, McQuadeRD, CarsonWH, AmanMG: A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry, 48:1110–1119, 2009.
11.
MillanMJ: Improving the treatment of schizophrenia: focus on serotonin (5-HT) 1A receptors. J Pharmacol Exp Ther, 295:853–861, 2000.
12.
OwenR, SikichL, MarcusRN, Corey–LisleP, ManosG, McQuadeRD, WilliamHC, FindlingRL: Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124:1533–1540, 2009.
13.
ReillyC: Autism spectrum disorders in Down syndrome: A review. Res Autism Spectr Disord, 3:829–839, 2009.
14.
SavasirI, SezginN, ErolN: Ankara Gelisim Tarama Envanteri (AGTE). El Kitabi, 1998.
15.
StarrEM, BerumentSK, TomlinsM, PapanikolaouK, RutterM: Brief report: Autism in individuals with Down syndrome. J Autism Dev Disord, 35:665–673, 2005.
16.
WhittleN, SartoriSB, DierssenM, LubecG, SingewaldN: Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics, 120:e1465–e1471, 2007.
